1215767-84-2 Usage
Description
5-bromo-7-chloroquinoline is a quinoline derivative, a heterocyclic compound characterized by a six-membered ring with four carbon atoms and two nitrogen atoms, along with a bromine and a chlorine atom attached to the ring. It is recognized for its potential in the synthesis of bioactive molecules and pharmaceutical drugs, as well as its applications in medicinal chemistry and as a fluorescent probe.
Uses
Used in Pharmaceutical Industry:
5-bromo-7-chloroquinoline is used as a building block for the synthesis of various bioactive molecules and pharmaceutical drugs, contributing to the development of new therapeutic agents due to its unique chemical structure and properties.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5-bromo-7-chloroquinoline is utilized as a precursor for the development of new therapeutic agents, leveraging its chemical reactivity and structural features to create novel compounds with potential medicinal applications.
Used as a Fluorescent Probe:
5-bromo-7-chloroquinoline is employed as a fluorescent probe for studying cellular processes, providing insights into biological mechanisms and interactions within the cellular environment due to its fluorescent properties.
Used in Organic Synthesis:
As a reagent in organic synthesis, 5-bromo-7-chloroquinoline is used to facilitate chemical reactions, enabling the creation of a variety of organic compounds for research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1215767-84-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,5,7,6 and 7 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1215767-84:
(9*1)+(8*2)+(7*1)+(6*5)+(5*7)+(4*6)+(3*7)+(2*8)+(1*4)=162
162 % 10 = 2
So 1215767-84-2 is a valid CAS Registry Number.
1215767-84-2Relevant articles and documents
New compound used as rearranged during transfection kinase inhibitor
-
, (2021/03/05)
The present invention relates to a compound, a pharmaceutical composition containing the compound, a preparation method of the compounds, and application of the same as a rearranged during transfection (RET) kinase inhibitor. The compound is a compound shown as formula (I), or a pharmaceutically acceptable salt, a prodrug, a solvent compound, a polymorph, an isomer and a stable isotope derivativethereof. The present invention also relates to the application of the compounds to treatment or prevention of RET kinase mediated related diseases like tumors and a method of using the compounds for the treatment of the diseases.
NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS
-
Page/Page column 234, (2017/03/14)
The present invention relates novel 6-6 bicyclic aromatic ring substituted nucleoside analogues of Formula (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as PRMT5 inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE
-
Page/Page column 47, (2010/04/06)
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
